Search research articles
Contact Us
Filters
Showing results (131-140 of 149) with videos related to
Page
of 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 7, 2001
Intensification of adjuvant chemotherapy: 5-year results of a randomized trial comparing conventional doxorubicin and cyclophosphamide with high-dose mitoxantrone and cyclophosphamide with filgrastim in operable breast cancer with 10 or more involved axillary nodes
P Fumoleau, F Chauvin, M Namer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 13, 2012
Supportive care organisation in France: an in depth study by the French speaking association for supportive care in cancer (AFSOS)
F Scotté, C Hervé, S Oudard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 20, 2004
Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study
C Pozzo, C Barone, J Szanto, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 10, 1998
Simultaneous high-dose external irradiation and daily cisplatin in unresectable, non-metastatic adenocarcinoma of the pancreas: a phase I-II study
T D Nguyen, S Theobald, P Rougier, et al.
British Journal of Cancer
|
July 20, 2007
Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancer
J-P Delord, J Bennouna, P Artru, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2004
Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU, and infusional 5-FU alone in advanced pancreatic carcinoma patients
M Ducreux, E Mitry, M Ould-Kaci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 16, 2002
A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma
M Ducreux, P Rougier, J-P Pignon, et al.
British Journal of Cancer
|
September 19, 2007
Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?
C Massard, J-J Voigt, A Laplanche, et al.
British Journal of Cancer
|
March 10, 2005
A phase I clinical and pharmacokinetic study of capecitabine (Xeloda) and irinotecan combination therapy (XELIRI) in patients with metastatic gastrointestinal tumours
J P Delord, J Y Pierga, V Dieras, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomy
E Pujade-Lauraine, J P Guastalla, N Colombo, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 149) with videos related to
Sort By:
Page
of 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 7, 2001
Intensification of adjuvant chemotherapy: 5-year results of a randomized trial comparing conventional doxorubicin and cyclophosphamide with high-dose mitoxantrone and cyclophosphamide with filgrastim in operable breast cancer with 10 or more involved axillary nodes
P Fumoleau, F Chauvin, M Namer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 13, 2012
Supportive care organisation in France: an in depth study by the French speaking association for supportive care in cancer (AFSOS)
F Scotté, C Hervé, S Oudard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 20, 2004
Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study
C Pozzo, C Barone, J Szanto, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 10, 1998
Simultaneous high-dose external irradiation and daily cisplatin in unresectable, non-metastatic adenocarcinoma of the pancreas: a phase I-II study
T D Nguyen, S Theobald, P Rougier, et al.
British Journal of Cancer
|
July 20, 2007
Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancer
J-P Delord, J Bennouna, P Artru, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2004
Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU, and infusional 5-FU alone in advanced pancreatic carcinoma patients
M Ducreux, E Mitry, M Ould-Kaci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 16, 2002
A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma
M Ducreux, P Rougier, J-P Pignon, et al.
British Journal of Cancer
|
September 19, 2007
Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?
C Massard, J-J Voigt, A Laplanche, et al.
British Journal of Cancer
|
March 10, 2005
A phase I clinical and pharmacokinetic study of capecitabine (Xeloda) and irinotecan combination therapy (XELIRI) in patients with metastatic gastrointestinal tumours
J P Delord, J Y Pierga, V Dieras, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomy
E Pujade-Lauraine, J P Guastalla, N Colombo, et al.
Page
of 15